OTTAWA, June 1 (Reuters) - An official Canadian panel on
Tuesday said people who received a first shot of AstraZeneca
PLC's COVID-19 vaccine can choose to receive a different
shot for their second dose, dealing another potential blow to
the pharmaceutical giant.
The non-binding recommendation from the National Advisory
Committee on Immunization (NACI) means Canadians can choose to
get second doses from Moderna Inc and Pfizer Inc
. This could hit demand for AstraZeneca's vaccine, which
has been linked to rare blood clots that can be fatal.
(Reporting by David Ljunggren and Steve Scherer in Ottawa and
Allison Martell in Toronto; Editing by Chizu Nomiyama)